*** Notice: For the protection of property rights, this catalog is available for online browsing only. Please drop us a line if you would like to receive a copiable version of this catalog. Thank You!
Presenters: I. Craig Henderson, MD; John Kennedy, MD, FRCPI; William Gradishar, MD; Claudine Isaacs, MD
Leading medical experts making presentations on advances in the management and treatment of breast cancer, including new agents and combination therapies, emphasizing the role of chemotherapy.
Presenters: Walter J. Curran, Jr., MD; David S. Ettinger, MD; Chandra P. Belani, MD; Dawn Moose, MD
Integration of Chemotherapy and Radiation for Non-Small Cell Lung Cancer; New Drugs in Treatment of NSCLC; Recent Improvements in the Management of NSCLC; Management of Anorexia and Cachexia for Patients w/ NSCLC.
Presenters: Walter J. Curran, Jr., MD; David S. Ettinger, MD; Chandra P. Belani, MD; Dawn Moose, MD
Integration of Chemotherapy and Radiation for Non-Small Cell Lung Cancer; New Drugs in Treatment of NSCLC; Recent Improvements in the Management of NSCLC; Management of Anorexia and Cachexia for Patients w/ NSCLC.
Presenters: Walter J. Curran, Jr., MD; David S. Ettinger, MD; Chandra P. Belani, MD; Dawn Moose, MD
Integration of Chemotherapy and Radiation for Non-Small Cell Lung Cancer; New Drugs in Treatment of NSCLC; Recent Improvements in the Management of NSCLC; Management of Anorexia and Cachexia for Patients w/ NSCLC.
Presenters: William U. Shipley, MD(Moderator); Derek Raghavan, MD, PhD; Harry W. Herr, MD; Mark S. Soloway, MD; M'Liss A. Hudson, MD; Niall M. Heney, MD; Paul F. Schellhammer, MD; Donald S. Kaufman, MD
Topics include superficial and invisible bladder cancer, diagnosis of patients presenting with either hematuria and dysuria, endoscopic and intravesical chemotherapeutic methods, systematic chemotherapy for advanced bladder cancer.
Presenters: Laszlo Tabar, MD; Linda Warren, MD; Richard Bird, MD; Jeffery Weinreb, MD; Kevin Fox, MD; Barbara Fowble, MD; Michael Osborne, MD; John Hainsworth, MD
Topics included in this program are: The effectiveness of mammographic screening; the diagnostic workup: mammography, sonography, MRI; and therapeutic options: radiotherapy, chemotherapy, and surgury.
Presenters: Leta Truett, RN, MN, CCRN; Deborah M. Thorpe, PhD, RN, CS; Mary Cunningham, RN, MS; Talulah Ruger, RN, BSN
This program features physicians and doctors discussing various appropriate nursing rules and interventions in pain management. The major areas of discussion are as follows: acute or post-operative pain management - current techniques and therapies, barriers to effective management; chronic non-malignant pain management or behavioral/cognitive pain management- classifications of chronic non-malignant pain characteristics, data collection, and treatment, cancer pain management - dosing regimens; nursing assessment for acute, chronic non-malignant or cancer pain - current therapies and techniques, point controlled analgesia (PCA), epidural analgesia.
Presenters: Gabriel Hortobagyi, MD; Barbara L. Weber, MD; Charles L. Vogel, MD
Intro on the Management of Advanced Breast Cancer and the Use of Standard Chemotherapy; Current Hormonal Therapy and New Hormonal Agents in the Management of Breast Cancer; New Agents, including Taxol and Taxotere; Use of Navelbine and Clinical Trial Results.
Presenters: Nicholas Petrelli, MD,FACS - Neal Meropol, MD - Tyvin Rich, MD - Alan Venook, MD
Topics include: surgical therapy of metastatic disease; new drugs in the treatment of metastatic disease; intrahepatic chemotherapy of colorectal liver metastasis; adjuvant combined modality therapy for colorectal cancer.
Presenters: Richard Champlin, MD; Bruce D. Cheson, MD; Michael Bishop, MD; Frederick R. Appelbuam, MD; Frank J. Giles, MD; Charles A. Schiffer, MD
For physicians who have interest in or occasion to diagnose or treat cancer patients. Presentations will feature discussions about various leukemias and treatments of the disease.
Presenters: Joseph Oesterling, MD; Arthur Porter, MD; Anthony Zeitman, MD; Jerry Ritchie, MD; David Paulson, MD; Michael K. Brawer, MD
Featured topics of this program include the use of PSA in diagnosis and staging of prostate cancer, transrectal ultrasound, improving the results of radical treatment for locally advanced prostate cancer, radical prostatectomy, maximum androgen deprivation therapy, and radionuclide therapy for metastatic prostate cancer.
Management of low grade lymphoma, status of interferon in Hon-Hodgkin's lymphoma, treatment of HIV/AIDS related lymphomas and treatment of low grade lymphoma.
Presenters: Everett E. Vokes, MD; Vince Miller, MD; Gregory A. Masters, MD; Bruce Hillner, MD
Most recent data in standard therapy for Stage IV; Describe the role of concurrent and chemoradiation in Stage III and other treatment, including vinorelbine tartrate and platinol; Understand the pharmcoeconomic impact; Identify early clinical results of current investigation on drugs; Discuss neoadjuvant treatment.
Presenters: Harold Harvey, MD; Richard Santen, MD; Paul Goss, MD; Andrea Manni, MD
Topics covered in this program include: new aromatase inhibitors; risks and benefits of adjuvant tamoxifen; potential prevention of breast cancer by hormonal therapies; optimal duration therapy with tamoxifen; post-menopausal estrogen replacement therapy.
Presenters: Seth Lerner, MD; Ron Bukowski, MD; Chris Logothetis, MD; Richard Williams, MD; Michael Sorodsky, MD
This program deals with testes cancer; bladder cancer- BCG, alternatives to BCG therapy, and metastatic bladder cancer; and renal cell cancer - single agent therapies including IL-2 high dose and alpha interferon, combination therapy of IL-2 low dose and alpha interferon, and surgery to treat renal cell - does it improve survivability
Presenters: Paul Shelhamer, MD; Charles Metzger, MD; Anthony Zeitman, MD; Mark Solloway, MD
A prestigious panel of physicians discussing the management of prostate cancer with specific topics including: anti-androgens and the treatment of metastatic prostate cancer; management of prostate disease in a single specialty managed care environment; neoadjuvant therapy and radiotherapy.
Presenters: Everett E. Vokes, MD; Philip C. Hoffman, MD; Vincent A. Miller, MD; Gregory Masters, MD; Roman Perez-Soler, MD
Familiarization with the most recent data in standard therapy for Stage IV; Discuss neoadjuvant treatment of NSCLC; Describe the role of concurrent and chemoradiation in Stage III; Identification of early clinical results of current investigation on drugs.
Presenters: Judd W. Moul, MD; Myra Glajchen, DSW; David G. McLeod, MD, JD; Nancy A. Dawson, MD
New paradigm of metastatic prostate cancer in the '90's; psychosocial aspects of metastatic prostate cancer and pain management; comparisons and contrasts of prostate cancer: patients vs. physicians; medicolegal aspects; medical oncology perspective of metastatic prostate cancer/pain control.
Presenters: Nicholas J. Vogelzang, MD; Robert Kilbourn, MD, PhD; Robert C. Flanigan, MD; Gerald W. Chodak, MD, FACS; Howard A. Burris, III, MD
Discuss the role of single agent chemotherapy or second line hormonal therapy for managing hormone refractory prostate cancer; describe results of clinical trials using combinations chemotherapy for metastatic, hormone-refractory prostate cancer; review the role of taxanes in treating metastatic disease. Be familiar with the most recent data for treating prostate cancer.
Presenters: Aman U. Buzdar, MD; I. Craig Henderson, MD; Howard Hochster, MD
Discuss the diagnosis and treatment of breast cancer; Presentations on 1st and 2nd line treatments will cover cytotoxic chemotherapy (CMF, CAF, and new cytotoxic agents); Diverse hormonal agents, neoadjuvant treatments, and combination therapies.